Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Debdeep Dey"'
Autor:
Vivek S. Radhakrishnan, Rajat Bajaj, Vasundhara Raina, Jeevan Kumar, Saurabh J. Bhave, Reghu K. Sukumaran Nair, Arijit Nag, Indu Arun, Lateef Zameer, Debdeep Dey, Neeraj Arora, Mayur Parihar, Jayanta Das, Rimpa B. Achari, Deepak K. Mishra, Mammen Chandy, Reena Nair
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
IntroductionDespite high cure rates with standard treatment, 30% patients with Hodgkin lymphoma develop relapsed or refractory (R/R) disease. Salvage therapy followed by autologous hematopoietic cell transplantation (HCT) is considered standard of ca
Externí odkaz:
https://doaj.org/article/dae1e4f52afa48cfae5a870c4b097c72
Autor:
Geetashree Mukherjee, Swarnendu Bag, Prasenjit Chakraborty, Debdeep Dey, Samrat Roy, Prateek Jain, Paromita Roy, Richie Soong, Partha Pratim Majumder, Suparna Dutt
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0242058 (2020)
The tumor immune microenvironment is emerging as a critical player in predicting cancer prognosis and response to therapies. However, the prognostic value of tumor-infiltrating immune cells in Gingivo-Buccal Oral Squamous Cell Carcinoma (GBOSCC) and
Externí odkaz:
https://doaj.org/article/50b8d16c272b48639af2d39cc512ca06
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 64, Iss 2, Pp 418-419 (2021)
Externí odkaz:
https://doaj.org/article/cb655ad7f9b441e5a7bd79c411ae5717
Autor:
Deepak Dabkara, Divya Midha, Argha Chatterjee, Tiyas Sen Dutt, Bivas Biswas, Sandip Ganguli, FNU Moses, FNU Geetasheree, Debdeep Dey, Sumit Mukhopadhay, Priya Ghosh, Sagar Basak, Soumen Chatterjee
Publikováno v:
The Indian Journal of Chest Diseases and Allied Sciences. 62:193-196
Autor:
Bhagat S. Lali, Debdeep Dey, Saurabh J. Bhave, Mayur Parihar, Dayanand Lingegowda, Jayanta Das, Suvadip Chatterjee
Publikováno v:
Indian Journal of Medical and Paediatric Oncology. 42:501-505
Large B-cell lymphomas include both the commonly encountered, as well as not so frequent entities. We report a rare case of hepatic intravascular large B-cell lymphoma (IVLBCL). These cases usually pose a major challenge to timely diagnosis due to th
Autor:
Neeraj Arora, Shekhar Krishnan, Subhajit Brahma, Debdeep Dey, Sambhunath Banerjee, Mammen Chandy, Vivek S. Radhakrishnan, Niharendu Ghara, Geetashree Mukherjee, Deepak Mishra, Tanusri Karmakar
Publikováno v:
Indian J Hematol Blood Transfus
Routine diagnostic biopsy tissue processing, conventional histology/immunohistochemistry (IHC) method is a multi-step and time consuming practice. With the advanced tissue dissociation protocols and panel designing, flow cytometric immunophenotyping
Autor:
Dipyaman Ganguly, Ayan Mukherjee, Dipika Sarkar, Bishnu Prasad Sinha, Kantubhukta Ramarao, Biswajit Kundu, Kasireddy Nagireddy, Nirmal Das, Sourav Pal, Deblina Raychaudhuri, Purbita Bandopadhyay, Debdeep Dey, Arindam Talukdar
Publikováno v:
Journal of Medicinal Chemistry. 64:9279-9301
Several toll-like receptors (TLRs) reside inside endosomes of specific immune cells-among them, aberrant activation of TLR7 and TLR9 is implicated in myriad contexts of autoimmune diseases, making them promising therapeutic targets. However, small-mo
Autor:
Neeraj Arora, Mukherjee H, Rizwan Javed, Debdeep Dey, Podder D, Vivek S. Radhakrishnan, Indu Arun, Piali Mandal, Sen S, R. Achari, Arijit Nag, Reghu K Sukumaran Nair, Jeevan Kumar, Latif Z, Mammen Chandy, Deepak Mishra, Mayur Parihar, Saurabh Jayanth Bhave
Publikováno v:
Indian J Hematol Blood Transfus
Standard treatment of primary central nervous system lymphoma (PCNSL) in countries with limited resources remains conventional chemotherapy, with or without whole brain radiotherapy (WBRT). To evaluate the treatment outcomes, prognostic factors and c
Autor:
Santam Chakraborty, Sanjoy Chatterjee, Selvamani Backianathan, Punita Lal, Subhash Gupta, Rosina Ahmed, Shagun Misra, Patricia Solomon, Rajesh Balakrishan, Subecha Bhushal, Debashree Guha, K.J. Maria Das, Anurupa Mahata, Samar Mandal, Abha Kumari, Henry Finlay Godson, Sandip Ganguly, C. Shamsudden, M. Dinesh, Debdeep Dey
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 174
HYPORT adjuvant trial is a randomised phase III open-label noninferiority trial comparing standard moderately hypofractionated 3 week adjuvant radiation therapy in breast cancer with a novel 1-week schedule. The trial was initiated in March 2019 and
Autor:
Debdeep Dey, Bhagat Singh Lali, Paromita Roy, Divya Midha, Indu Arun, Lateef Zameer, Anand Bardia, Geetashree Mukherjee
Publikováno v:
Ecancermedicalscience. 16
A central review of histopathology specimens at tertiary oncology hospitals is important for optimum patient care in the modern era of personalised medicine. The challenges of healthcare delivery and access to ancillary investigations faced by a path